The International Formulations business operates in the generics and branded generics space across the geographies of Canada, Europe, Australia & New Zealand, South America and Emerging Markets.
With strong foothold in immunosuppressants, RPG Life Sciences partners with leading generic players of the world. Quality consciousness and high service levels make RPG Life Sciences a Preferred Partner.
In the branded generics space, RPG Life Sciences is the leader in Nephrology segment in Egypt, Kenya & Myanmar with a dedicated field force. It plans to further strengthen its presence in Nephrology while building on the Oncology & Critical Care Portfolio.